Videos

SCAI President James Hermiller, MD, discusses the need for more better radiation protection in the cath lab#SCAI #CathLab, #RadiationExposure #cardiology

SCAI leaders 'on a mission' to improve cath lab protection from radiation, orthopedic injury

SCAI President James Hermiller, Jr., MD, explains the need for more innovative radiation protection systems in the cath lab.

Evan Scott Shlofmitz, DO, Director of Intravascular Imaging, St. Francis Hospital, in Roslyn, New York, explains how he uses Heartflow's artificial intelligence technology to assess a patient's coronary artery disease from noninvasive CT scans to preplan PCI procedures.

How AI and CCTA help heart teams plan ahead before PCI

Evan Shlofmitz, DO, director of intravascular imaging at St. Francis Hospital, explains how advanced artificial intelligence technology is used to assess a patient's CT scan before they undergo PCI.

Charalambos Antoniades, MD, the British Heart Foundation Chair of Cardiovascular Medicine at the University of Oxford, is a co-founder of the company Caristo, which has developed technology to image coronary inflammation on coronary computed tomography angiography (CCTA) scans to visualize a key factor of residual cardiovascular risk.

Detecting coronary inflammation on CT imaging could reshape preventive cardiology

New technology now being considered by the FDA for approval can capture coronary inflammation on CCTA images and provide risk assessments. What could this mean for the future of cardiac care? We spoke to one researcher to learn more.

Aakriti Gupta, MD, Cedars-Sinai, explains use of cerebral embolic protection devices in TAVR

An updated look at the use of cerebral embolic protection devices during TAVR

Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke.

Deepak L. Bhatt, MD, discusses research and drug therapies in development to treat lipoprotein (a). #Lp(a)

New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care

Lipoprotein (a) research is on the rise in recent years. Deepak Bhatt, MD, director of Mount Sinai Fuster Heart Hospital, explains why this trend is so important.

Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

ACC Vice President Christopher Kramer, MD, FACC, offers an update on the creation of a new cardiovascular board.

Final decision on the creation of a new cardiovascular board expected soon

U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision is expected by the end of February. 

ACC President Cathie Biga explains the American College of Cardiology advocacy efforts in Washington D.C. in 2025.

ACC president details key advocacy efforts in cardiology

American College of Cardiology President Cathie Biga, MSN, says Medicare payment reform remains a top priority going forward. Site-neutral payments and improved access to PAD screening are two other issues close to the ACC's heart. 

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.